Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 39450 securities pursuant to ESOP/ESPS at its meeting held on October 10, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma Limited has allotted 39,450 securities to eligible employees under its Employee Stock Option Plan (ESOP) or Employee Stock Purchase Scheme (ESPS). The allotment was approved at a board meeting held on October 10, 2025. This is a routine corporate action involving the issuance of fresh shares to employees as part of their compensation. The company has informed the stock exchange about this allotment as required under listing regulations.
This is a routine ESOP allotment with a relatively small number of shares, so it is unlikely to have any meaningful impact on the stock price. It reflects the company rewarding its employees through equity-based compensation, which is a common practice.